Add to my selection

HEPCLUDEX (bulévirtide)

Medicine - Posted on Aug 07 2025

Active substance (DCI)

bulévirtide

history (2)

6/11/25

HEPCLUDEX (bulevirtide) - Hepatitis delta virus (HDV) adult and paediatric patients 3 years of age and older

Summary of opinion Favourable opinion for reimbursement in the treatment of chronic hepatitis delta virus (HDV) infection in...

CAV :
54321

icône flèche
12/16/20

HEPCLUDEX (bulevirtide)

Key points Favourable opinion for reimbursement only in the treatment of chronic hepatitis delta virus (HDV) infection in pl...

CAV :
54321

icône flèche

Technical information

ATC code

J05AX28

Manufacturer

GILEAD SCIENCES

Presentation

HEPCLUDEX 2 mg, poudre pour solution injectable
30 flacons en verre (CIP : 34009 302 112 8 1)

All our publications